Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

43.42 -0.37 (-0.83%)
Streaming Delayed Price Updated: 2:56 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,501,745
Open 43.79
Bid (Size) 43.42 (24)
Ask (Size) 43.43 (33)
Prev. Close 43.79
Today's Range 43.40 - 44.13
52wk Range 41.45 - 56.32
Shares Outstanding 5,606,688,356
Dividend Yield 3.59%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The War Room/DailyClout Pfizer Documents Analysis Volunteers Publish e-Book that Soars to Number Five on Amazon in Three Days
A week before Project Veritas' exposé of a Pfizer Director of mRNA Research and Development admitting his company engages in Directed Evolution, the War Room/DailyClout Experts published an in-depth... 
Via Newsworthy
Topics Lawsuit
Exposures Financial Legal
A New Era In Science Funding: VitaDAO Raises $4.1M For Longevity Research Projects
Decentralized autonomous organization VitaDAO, which provides funding for longevity science research, has concluded a successful funding round, raising $4.1 million. 
Via Benzinga

Performance

YTD
-15.28%
-15.28%
1 Month
-15.25%
-15.25%
3 Month
-6.71%
-6.71%
6 Month
-14.20%
-14.20%
1 Year
-17.58%
-17.58%

More News

Read More
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
Via Benzinga
The RSV Vaccine Battle Wages On With Moderna Scoring A Win Vs. Pfizer, GSK
Via Investor's Business Daily
Pfizer's Earnings Outlook
Via Benzinga
What 10 Analyst Ratings Have To Say About Pfizer
Via Benzinga
Capturing the U.S. Health Care Space with XLV
Via Get News
Topics ETFs
Exposures COVID-19
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
Via Benzinga
MarketBeat Week in Review – 1/23- 1/27
Via MarketBeat
Topics Economy Workforce
Exposures Economy Interest Rates Layoff
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
Via Investor's Business Daily
Tesla, Intel, Pfizer, Visa, Northrop Grumman: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
Why This Pfizer Analyst Is No Longer Bullish On The COVID Stock
Via Benzinga
Most Active Equity Options For Midday - Wednesday, Jan. 26
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
Via Benzinga
NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
How Could GSK's RSV Vaccine Change its Valuation?
Via MarketBeat
Exposures Product Safety
7 Cream-of-the-Crop Stocks to Buy Today
Via InvestorPlace
Thursday Predictions: 3 Hot Stocks for Tomorrow
Via InvestorPlace
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
Via Benzinga
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Via MarketBeat
A Comprehensive Study Exploring Balantidiasis Market : Key Players Fougera Pharmaceuticals, Medtronic, NuVasive
Via SBWire
When Does Pfizer Become A Bargain?
Via MarketBeat
Exposures COVID-19
3 Stocks to Buy With a Forward P/E of Less Than 10
Via InvestorPlace
COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today
Via Benzinga
Tumor Lysis Syndrome Market Projected to Show Strong Growth : AbbVie, Hikma Pharmaceuticals, Amgen, Genentech
Via SBWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.